PubMed Central , Free Radical Biology and Medicine , vol
With these points in mind, we undertook a broad assessment of published clinical data, curating the body weight loss (% from baseline), glycosylated hemoglobin levels (HbA1c), and nausea responses (% patients reporting) from the SUSTAIN 3, SUSTAIN 7, SCALE Diabetes, SURPASS 2, and STEP 2 trials (17, 22, 64, 66, 67) ( Figures 1AC )
As GLP-1 use grows, only an expert navigation partner can manage these many variables and use cases
While compounded versions were often more affordable, the FDA stated that affordability concerns require different policy solutions and not continued compounding of drugs with known safety risks
Presented for research literature review only Lens S (2026)